机译:设计方法概述以及针对欧盟DEMO的研发活动的优先级
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
Forschungszentrum Julich, Inst Energy & Climate Res, Julich, Germany|Univ Ghent, Dept Appl Phys, Ghent, Belgium;
Karlsruhe Inst Technol, Campus Nord Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
Karlsruhe Inst Technol, Campus Nord Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
Ansaldo Nucl, Corso Perrone 25, I-16152 Genoa, Italy;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
CIEMAT, Avda Complutense 40, E-28040 Madrid, Spain;
CCFE Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
Karlsruhe Inst Technol, Campus Nord Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
CCFE Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England;
Ecole Polytech Fed Lausanne, Swiss Plasma Ctr, Stn 13, CH-1015 Lausanne, Switzerland;
Max Planck Inst Plasma Phys, Boltzmannstr 2, D-85748 Garching, Germany;
EUROfus Consortium, Boltzmannstr 2, D-85748 Garching, Germany;
CEN Cadarache, Cryomagnet Grp, F-13108 St Paul Les Durance, France;
DEMO; Fusion reactors; Design integration; Systems engineering; Systems code;
机译:欧盟DEMO设计和研发活动概述
机译:CEA在欧盟演示反应堆低温电磁系统设计活动和相关研发方面的进展
机译:在CEA对欧盟演示反应堆冷冻系统设计活动和相关研发的进展
机译:用于评估和支持巴西消费电子行业跨国公司研发实验室管理的技术创意组合的方法
机译:第一部分。具有吲哚胺2,3-二加氧酶抑制剂潜在活性的旋光色氨酸衍生物的合成:一种通过不对称催化氢化的方法。第二部分。含α1的GABA(A)/苯并二氮杂receptor受体亚型的选择性配体的设计,合成和药理作用:位于-3和-6位的β-咔啉及其相应的二价配体的SAR研究。第三部分。重要生物遗传中间体,(+)-聚神经氨酸和(+)-聚神经氨酸醛,以及16-表-维西辛和Macusine A的首次对映体全合成。
机译:类风湿性关节炎患者疾病活动自我管理方法的共同设计
机译:概述欧盟DEmO的研发活动的设计方法和优先次序
机译:欧盟关于DEmO液态金属增殖毯的活动概述